Vimarsana
Biggest News Aggregation in the World

Page 9 - Reporting Considerations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reporting Considerations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reporting Considerations Today - Breaking & Trending Today

Lefteris Acquisition Corp. Provides Update on Periodic Reporting - Vimarsana News

Lefteris Acquisition Corp. Provides Update on Periodic Reporting

/PRNewswire/ -- As previously announced on May 21, 2021, Lefteris Acquisition Corp. (Nasdaq: LFTR) (the "Company") has determined to restate its 2020 financial...

Lazydays Holdings, Inc. Receives Nasdaq Notice on Late Filing of its Form 10-Q - Vimarsana News

Lazydays Holdings, Inc. Receives Nasdaq Notice on Late Filing of its Form 10-Q

/PRNewswire/ -- Lazydays Holdings, Inc. (NasdaqCM: LAZY) today announced that it has received a notice from The Nasdaq Stock Market on May 25, 2021 notifying...

Stemming from SEC Guidance Concerning Balance Sheet Treatment of Warrants, TZP Strategies Acquisition Corp. Announces Receipt of Nasdaq Continued Listing Standard Notice - Vimarsana News

Stemming from SEC Guidance Concerning Balance Sheet Treatment of Warrants, TZP Strategies Acquisition Corp. Announces Receipt of Nasdaq Continued Listing Standard Notice

/PRNewswire/ -- TZP Strategies Acquisition Corp. (Nasdaq: TZPS) (the "Company") today announced that it received a deficiency letter from the Nasdaq Capital...

MDH Acquisition Corp. Regulatory Filing Requirement - Vimarsana News

MDH Acquisition Corp. Regulatory Filing Requirement

Share this article Share this article NEW YORK, May 28, 2021 /PRNewswire/ -- MDH Acquisition Corp. (NYSE: MDH) (the "Company") announced today that it received a notice from the New York Stock Exchange (the "NYSE") indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the "Q1 2021 Report") with the U.S. Securities and Exchange Commission (the "SEC").  As indicated in the Form 12b-25 filed by the Company with the SEC on May 17, 202...

Ibere Pharmaceuticals Receives Expected NYSE Notice Regarding Delayed Quarterly Report - Vimarsana News

Ibere Pharmaceuticals Receives Expected NYSE Notice Regarding Delayed Quarterly Report

/PRNewswire/ -- Ibere Pharmaceuticals (NYSE: IBER) (the "Company") today announced that it received a notice on May 25, 2021 from the New York Stock Exchange...